{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,27]],"date-time":"2026-06-27T13:26:46Z","timestamp":1782566806955,"version":"3.54.5"},"reference-count":35,"publisher":"Public Library of Science (PLoS)","issue":"5","license":[{"start":{"date-parts":[[2021,5,19]],"date-time":"2021-05-19T00:00:00Z","timestamp":1621382400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"abstract":"<jats:sec id=\"sec001\">\n<jats:title>Objectives<\/jats:title>\n<jats:p>Saline and Plasma-Lyte have different physiochemical contents; consequently, they may differently affect patients\u2019 renal function. We compared the effects of fluid therapy with 0.9% saline and with Plasma-Lyte 148 on renal function as assessed by creatinine concentration among patients undergoing major surgery.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec002\">\n<jats:title>Methods<\/jats:title>\n<jats:p>We conducted a prospective, double-blinded cluster crossover trial comparing the effects of the two fluids on major surgery patients. The primary aim was to establish the pilot feasibility, safety and preliminary efficacy evidence base for a large interventional trial to establish whether saline or Plasma-Lyte is the preferred crystalloid fluid for managing major surgery patients. The primary efficacy outcome was the proportion of patients with changes in renal function as assessed by creatinine concentration during their index hospital admission. We used changes in creatinine to define acute kidney injury (AKI) according to the RIFLE criteria.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec003\">\n<jats:title>Results<\/jats:title>\n<jats:p>The study was feasible with 100% patient and clinician acceptance. There were no deviations from the trial protocol. After screening, we allocated 602 patients to saline and 458 to Plasma-Lyte. The median (IQR) volume of intraoperative fluid received was 2000 mL (1000:2000) in both groups. Forty-nine saline patients (8.1%) and 49 Plasma-Lyte patients (10.7%) developed a postoperative AKI (adjusted incidence rate ratio [aIRR]: 1.34; 95% CI: 0.93\u20131.95; p = 0.120). No differences were observed in the development of postoperative complications (aIRR: 0.98; 95% CI: 0.89\u20131.08) or the severity of the worst complication (aIRR: 1.00; 95% CI: 0.78\u20131.30). The median (IQR) length of hospital stay was six days (3:11) for the saline group and five days (3:10) for the Plasma-Lyte group (aIRR: 0.85; 95% CI: 0.73\u20130.98). There were no serious adverse events relating to the trial fluids, nor were there fluid crossover or contamination events.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec004\">\n<jats:title>Conclusions<\/jats:title>\n<jats:p>The study design was feasible to support a future follow-up larger clinical trial. Patients treated with saline did not demonstrate an increased incidence of postoperative AKI (defined as changes in creatinine) compared to those treated with Plasma-Lyte. Our findings imply that clinicians can reasonably use either solution intraoperatively for adult patients undergoing major surgery.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec005\">\n<jats:title>Trial registration<\/jats:title>\n<jats:p>Registry: Australian New Zealand Clinical Trials Registry; ACTRN12613001042730; URL: <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"https:\/\/www.anzctr.org.au\/Trial\/Registration\/TrialReview.aspx?id=364988\" xlink:type=\"simple\">https:\/\/www.anzctr.org.au\/Trial\/Registration\/TrialReview.aspx?id=364988<\/jats:ext-link>.<\/jats:p>\n<\/jats:sec>","DOI":"10.1371\/journal.pone.0251718","type":"journal-article","created":{"date-parts":[[2021,5,19]],"date-time":"2021-05-19T17:49:16Z","timestamp":1621446556000},"page":"e0251718","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":8,"title":["The effects of 0.9% saline versus Plasma-Lyte 148 on renal function as assessed by creatinine concentration in patients undergoing major surgery: A single-centre double-blinded cluster crossover trial"],"prefix":"10.1371","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7403-7680","authenticated-orcid":true,"given":"Laurence","family":"Weinberg","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4305-399X","authenticated-orcid":true,"given":"Michael Hua-Gen","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leonid","family":"Churilov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"Macgregor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kent","family":"Garrett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jade","family":"Eyles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rinaldo","family":"Bellomo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2021,5,19]]},"reference":[{"issue":"9","key":"pone.0251718.ref001","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.2215\/CJN.00710113","article-title":"World incidence of AKI: a meta-analysis. Clinical journal of the American Society of Nephrology","volume":"8","author":"P Susantitaphong","year":"2013","journal-title":"Clin J Am Soc Nephrol"},{"issue":"24","key":"pone.0251718.ref002","first-page":"2263","article-title":"Australian and New Zealand College of Anaesthetists Clinical Trials Network and the Australian and New Zealand Intensive Care Society Clinical Trials Group. Restrictive versus Liberal Fluid Therapy for Major Abdominal Surgery","volume":"378","author":"PS Myles","year":"2018","journal-title":"N Engl J Med"},{"issue":"2","key":"pone.0251718.ref003","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.clnu.2008.01.008","article-title":"The history of 0.9% Saline","volume":"27","author":"S Awad","year":"2008","journal-title":"Clin Nutr"},{"issue":"13","key":"pone.0251718.ref004","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1056\/NEJMra1208627","article-title":"Resuscitation fluids","volume":"369","author":"JA Myburgh","year":"2013","journal-title":"N Engl J Med"},{"issue":"5","key":"pone.0251718.ref005","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1097\/SLA.0b013e31825074f5","article-title":"Major complications, mortality, and resource utilization after open abdominal surgery: 0.9% Saline compared to Plasma-Lyte","volume":"255","author":"AD Shaw","year":"2012","journal-title":"Ann Surg"},{"issue":"2","key":"pone.0251718.ref006","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1213\/ANE.0b013e318293d81e","article-title":"Hyperchloremia after noncardiac surgery is independently associated with increased morbidity and mortality: A propensity-matched cohort study","volume":"117","author":"SA McCluskey","year":"2013","journal-title":"Anesth Analg"},{"issue":"15","key":"pone.0251718.ref007","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1001\/jama.2012.13356","article-title":"Association between a chloride-liberal vs chloride-restrictive intravenous fluid administration strategy and kidney injury in critically ill adults","volume":"308","author":"NM Yunos","year":"2012","journal-title":"JAMA"},{"issue":"1","key":"pone.0251718.ref008","first-page":"24","article-title":"Meta-analysis of high- versus low-chloride content in perioperative and critical care fluid resuscitation","volume":"102","author":"ML Krajewski","journal-title":"Br J Surg. 2015"},{"issue":"7","key":"pone.0251718.ref009","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1097\/CCM.0000000000000305","article-title":"Association between the choice of IV crystalloid and in-hospital mortality among critically ill adults with sepsis","volume":"42","author":"K Raghunathan","year":"2014","journal-title":"Crit Care Med"},{"issue":"1","key":"pone.0251718.ref010","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1186\/s13054-015-1045-z","article-title":"Impact of intravenous fluid composition on outcomes in patients with systemic inflammatory response syndrome","volume":"1219","author":"AD Shaw","year":"2015","journal-title":"Crit Care"},{"issue":"1","key":"pone.0251718.ref011","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1177\/0310057X1804600112","article-title":"Associations of fluid amount, type, and balance and acute kidney injury in patients undergoing major surgery","volume":"46","author":"L Weinberg","year":"2018","journal-title":"Anaesth Intensive Care"},{"issue":"16","key":"pone.0251718.ref012","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1001\/jama.2015.12334","article-title":"SPLIT Investigators; ANZICS CTG. Effect of a buffered crystalloid solution vs saline on acute kidney injury among patients in the intensive care unit: The SPLIT Randomized Clinical Trial","volume":"314","author":"P Young","year":"2015","journal-title":"JAMA"},{"issue":"10","key":"pone.0251718.ref013","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1164\/rccm.201607-1345OC","article-title":"SALT Investigators and the pragmatic critical care research group; SALT Investigators. Balanced Crystalloids versus Saline in the Intensive Care Unit. The SALT Randomized Trial","volume":"195","author":"MW Semler","year":"2017","journal-title":"Am J Respir Crit Care Med."},{"issue":"9","key":"pone.0251718.ref014","first-page":"CD004089","article-title":"Perioperative administration of buffered versus non-buffered crystalloid intravenous fluid to improve outcomes following adult surgical procedures","volume":"9","author":"S Bampoe","year":"2017","journal-title":"Cochrane Database Syst Rev."},{"issue":"6","key":"pone.0251718.ref015","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1007\/s00134-017-4772-6","article-title":"Effects of restricting perioperative use of intravenous chloride on kidney injury in patients undergoing cardiac surgery: the LICRA pragmatic controlled clinical trial","volume":"43","author":"D McIlroy","year":"2017","journal-title":"Intensive Care Med"},{"issue":"9","key":"pone.0251718.ref016","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1056\/NEJMoa1711586","article-title":"SALT-ED Investigators. Balanced crystalloids versus saline in noncritically ill adults","volume":"378","author":"WH Self","year":"2018","journal-title":"N Engl J Med"},{"issue":"9","key":"pone.0251718.ref017","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1056\/NEJMoa1711584","article-title":"Balanced crystalloids versus saline in critically ill adults","volume":"378","author":"MW Semler","year":"2018","journal-title":"N Engl J Med"},{"issue":"4","key":"pone.0251718.ref018","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1097\/ALN.0000000000003130","article-title":"Saline versus Lactated Ringer\u2019s Solution. The Saline or Lactated Ringer\u2019s (SOLAR) Trial","volume":"132","author":"K Maheshwari","year":"2020","journal-title":"Anesthesiology"},{"issue":"9633","key":"pone.0251718.ref019","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/S0140-6736(08)60878-8","article-title":"An estimation of the global volume of surgery: a modelling strategy based on available data","volume":"372","author":"TG Weiser","year":"2008","journal-title":"Lancet"},{"issue":"1","key":"pone.0251718.ref020","first-page":"29","article-title":"Overview of the study protocols and statistical analysis plan for the Saline vs Plasma-Lyte 148 for Intravenous Fluid Therapy (SPLIT) research program","volume":"17","author":"SK Reddy","year":"2015","journal-title":"Crit Care Resusc."},{"key":"pone.0251718.ref021","first-page":"1","article-title":"KDIGO 2012 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease","volume":"3","author":"Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group","year":"2013","journal-title":"Kidney Inter Suppl"},{"issue":"4","key":"pone.0251718.ref022","doi-asserted-by":"crossref","first-page":"235","DOI":"10.5492\/wjccm.v5.i4.235","article-title":"Plasma-Lyte 148: A clinical review","volume":"5","author":"L Weinberg","year":"2016","journal-title":"World J Crit Care Med"},{"issue":"4","key":"pone.0251718.ref023","doi-asserted-by":"crossref","first-page":"R204","DOI":"10.1186\/cc2872","article-title":"Acute Dialysis Quality Initiative workgroup. Acute renal failure\u2013definition, outcome measures, animal models, fluid therapy and information technology needs: the Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group","volume":"8","author":"R Bellomo","year":"2004","journal-title":"Critical Care"},{"issue":"12","key":"pone.0251718.ref024","doi-asserted-by":"crossref","first-page":"4263","DOI":"10.1093\/ndt\/gfs375","article-title":"A European Renal Best Practice (ERBP) position statement on the Kidney Disease Improving Global Outcomes (KDIGO) clinical practice guidelines on acute kidney injury: part 1: definitions, conservative management and contrast-induced nephropathy","volume":"27","author":"Ad-hoc working group of ERBP","year":"2012","journal-title":"Nephrol Dial Transplant"},{"issue":"10","key":"pone.0251718.ref025","doi-asserted-by":"crossref","first-page":"544","DOI":"10.5694\/j.1326-5377.2009.tb03307.x","article-title":"A classification of hospital-acquired diagnoses for use with routine hospital data","volume":"191","author":"TJ Jackson","year":"2009","journal-title":"Med J Aust"},{"issue":"2","key":"pone.0251718.ref026","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1097\/01.sla.0000133083.54934.ae","article-title":"Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey","volume":"240","author":"D Dindo","year":"2004","journal-title":"Ann Surg"},{"issue":"2","key":"pone.0251718.ref027","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1097\/EJA.0000000000000118","article-title":"European Society of Anaesthesiology (ESA) and the European Society of Intensive Care Medicine (ESICM); European Society of Anaesthesiology; European Society of Intensive Care Medicine. Standards for definitions and use of outcome measures for clinical effectiveness research in perioperative medicine: European Perioperative Clinical Outcome (EPCO) definitions: a statement from the ESA-ESICM joint taskforce on perioperative outcome measures","volume":"32","author":"I Jammer","year":"2015","journal-title":"Eur J Anaesthesiol"},{"issue":"7","key":"pone.0251718.ref028","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1093\/aje\/kwh090","article-title":"A modified Poisson regression approach to prospective studies with binary data","volume":"159","author":"G. Zou","year":"2004","journal-title":"Am J Epidemiol"},{"issue":"3","key":"pone.0251718.ref029","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1056\/NEJMe1906559","article-title":"New guidelines for statistical reporting in the Journal","volume":"381","author":"D Harrington","year":"2019","journal-title":"NEJM"},{"issue":"10","key":"pone.0251718.ref030","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1164\/rccm.201709-1874LE","article-title":"We Do Not Appreciate SALT","volume":"197","author":"JL Vincent","year":"2018","journal-title":"Am J Respir Crit Care Med"},{"issue":"6","key":"pone.0251718.ref031","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1016\/j.bja.2018.02.026","article-title":"Another nail in the saline coffin","volume":"120","author":"HJ Priebe","year":"2018","journal-title":"Br J Anaesth"},{"issue":"16","key":"pone.0251718.ref032","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1001\/jama.2015.12390","article-title":"Assessing toxicity of intravenous crystalloids in critically ill patients","volume":"314","author":"JA Kellum","year":"2015","journal-title":"JAMA"},{"issue":"2","key":"pone.0251718.ref033","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.bja.2017.11.090","article-title":"Intravenous fluids: effects on renal outcomes","volume":"120","author":"DJ McLean","year":"2018","journal-title":"Br J Anaesth"},{"issue":"3","key":"pone.0251718.ref034","doi-asserted-by":"crossref","first-page":"F587","DOI":"10.1152\/ajprenal.00130.2018","article-title":"\"I don\u2019t get no respect\": the role of chloride in acute kidney injury","volume":"316","author":"JL Rein","year":"2019","journal-title":"Am J Physiol Renal Physiol"},{"key":"pone.0251718.ref035","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1186\/s40560-018-0320-x","article-title":"Balanced crystalloids versus isotonic Saline in critically ill patients: systematic review and meta-analysis","volume":"6","author":"YZM Zayed","year":"2018","journal-title":"J Intensive Care"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0251718","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,19]],"date-time":"2021-05-19T17:49:50Z","timestamp":1621446590000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0251718"}},"subtitle":[],"editor":[{"given":"Felipe","family":"Dal Pizzol","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2021,5,19]]},"references-count":35,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2021,5,19]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0251718","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,5,19]]}}}